June 26, 2018
New Financing to Help EyeQue Put Personal Vision Devices in Every Home and School; Stanford University’s Dr. William H. Robinson Joins Board of Directors
NEWARK, Calif. – June 26, 2018 – EyeQue™, the leader of at-home vision testing, announced today it has raised $11.2 million in a Series B round from existing investors. The funds will be used to help the company on its mission to eliminate extraneous trips to the optometrist and make at-home vision testing a reality for people across the globe. EyeQue’s patented technology allows people to test their vision, check if they need vision correction, and use the results to order eyeglasses online. This Series B investment brings the total equity raised to date to $16.2 million.
“At-home vision testing has the potential to dramatically improve the well-being of millions of people worldwide,” said Tibor Laczay, co-founder and CEO of EyeQue. “Over 2.5 billion people across the globe need glasses and don’t have them – whether they don’t have access to solutions, can’t afford them, or may not even realize their vision is impaired due to lack of healthcare services. At-home vision testing is more necessary than ever, and this round of financing will enable us to further pursue our dream of making vision care accessible and affordable to everyone.”
With the fitness wearable devices market projected to reach more than $48 billion in revenue by 2023, today’s consumer is more engaged in personalized wellness than ever – yet at-home vision tools are virtually non-existent. In 2015, Tibor Láczay and John Serri founded EyeQue to inspire people to learn about and care for their eyes by putting affordable, accurate vision tests directly into their hands, without having to make a trip to the doctor’s office.
EyeQue has developed two intelligent consumer vision solutions – the Insight and the Personal Vision Tracker – leveraging patented processing algorithms and optical technologies that present test results and track vision changes over time. These EyeQue devices are currently available and sold directly to consumers.
“We’ve challenged people to think differently about vision care and to take an active role in their eye health by introducing the world’s first smartphone enabled at-home vision tests. With our first-generation products, we’ve provided a way for people to test their vision, track changes, and even order new eyeglasses with their results,” said John Serri, PhD, co-founder and CTO of EyeQue. “With this infusion of capital, we will accelerate product development, service enhancements, and product launches.”
Dr. William H. Robinson, Professor of Medicine at Stanford University, has joined EyeQue’s Board of Directors. Dr. Robinson is a pioneer of innovative personal healthcare and will provide valuable insight and guidance to the team.
“I am excited to join the EyeQue Board and team in their quest to transform eye care, by enabling individuals to monitor and test their vision with affordable smartphone-enabled devices from the convenience of their homes,” said Dr. Robinson.
EyeQue™ is the leader of at-home vision testing, bringing affordable eye care to everyone. The Company is dedicated to putting accurate vision tests directly into the hands of people around the world. Based on patented technologies, EyeQue’s intelligent vision solutions allow people anywhere to self-administer vision tests using an optical smartphone attachment, mobile application, and a secure cloud-based processing and service center. The Company innovates from its Silicon Valley headquarters.
EyeQue does not issue prescriptions. While using the EyeQue Personal Vision Tracker has the benefits of accurately measuring refractive error and detecting changes between regular eye exams, it does not replace a comprehensive eye exam that evaluates ocular health and binocularity. EyeQue recommends people visit an eye care professional annually to receive a complete eye health exam.
Follow @EyeQueCorp on Facebook, Twitter and LinkedIn
InkHouse PR for EyeQue